Abstract
T cells specific for haptens determine immunopathology, as for the recognition of the β-lactamic ring by CD4+ T helper cells, responsible for the severe immune response to Penicillin in allergic patients. In this review we report studies that address functional and molecular aspects of hapten recognition by α/β T cells, enlightening the most relevant examples of hapten-specific T cells and their role in vivo. Using Trinitrophenyl as a contact allergen model and tumor associated carbohydrate antigens (TACA) as antigen models in cancer, our laboratory extensively studied T cell recognition by hapten-specific T cells suggesting new, unexplored avenues for T cell-based immunotherapy. In fact, the evidence of hapten recognition by “conventional” α/β T cells is of a critical importance in designing new immunotherapeutic approaches to treat allergies, cancer and chronic viral diseases.
Keywords: Haptens, drugs, metals, TACA, antigen presenting cells, T cells, immunotherapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Hapten Recognition by T Cells: A Functional and Molecular View
Volume: 8 Issue: 4
Author(s): Alessandra Franco
Affiliation:
Keywords: Haptens, drugs, metals, TACA, antigen presenting cells, T cells, immunotherapy
Abstract: T cells specific for haptens determine immunopathology, as for the recognition of the β-lactamic ring by CD4+ T helper cells, responsible for the severe immune response to Penicillin in allergic patients. In this review we report studies that address functional and molecular aspects of hapten recognition by α/β T cells, enlightening the most relevant examples of hapten-specific T cells and their role in vivo. Using Trinitrophenyl as a contact allergen model and tumor associated carbohydrate antigens (TACA) as antigen models in cancer, our laboratory extensively studied T cell recognition by hapten-specific T cells suggesting new, unexplored avenues for T cell-based immunotherapy. In fact, the evidence of hapten recognition by “conventional” α/β T cells is of a critical importance in designing new immunotherapeutic approaches to treat allergies, cancer and chronic viral diseases.
Export Options
About this article
Cite this article as:
Franco Alessandra, Hapten Recognition by T Cells: A Functional and Molecular View, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2009; 8 (4) . https://dx.doi.org/10.2174/187152309789839019
DOI https://dx.doi.org/10.2174/187152309789839019 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Current Medicinal Chemistry Mechanisms Underlying Chemopreventive Effects of Flavonoids via Multiple Signaling Nodes within Nrf2-ARE and AhR-XRE Gene Regulatory Networks
Current Chemical Biology The Role of Angiogenesis as a Prognostic Factor of Breast Cancer: Recent Review
Current Women`s Health Reviews Antisense Oligodeoxynucleotide Therapy for Prostate Cancer Targeting Antiapoptotic Genes Involved in the Mechanism Mediating Progression to Androgen Independence
Current Signal Transduction Therapy Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents
Current Topics in Medicinal Chemistry Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis
Current Aging Science Synthesis of Asymmetric 1-Thiocarbamoyl Pyrazoles as Potent Anti- Colon Cancer, Antioxidant and Anti-Inflammatory Agent
Anti-Cancer Agents in Medicinal Chemistry Peptides Targeting Angiogenesis Related Growth Factor Receptors
Current Pharmaceutical Design Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models
Anti-Cancer Agents in Medicinal Chemistry Naturally Occurring Hydroxytyrosol: Synthesis and Anticancer Potential
Current Medicinal Chemistry Cytochrome P450 2C8 and Drug Metabolism
Current Topics in Medicinal Chemistry A Brief Evaluation of Tumor Imaging in Mice with 99mTc-glucarate Including a Comparison with 18F-FDG
Current Radiopharmaceuticals Management of Early Stage Cervical Cancer
Reviews on Recent Clinical Trials Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Cardiovascular & Hematological Agents in Medicinal Chemistry Tyrosine Kinase Inhibitors
Current Cancer Drug Targets Gene Expression Abnormalities in Thymoma
Current Pharmacogenomics Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Current Pharmaceutical Design